Table 2.
NSAIDs | Frog CAP IC50 (mM) |
TTX-Sensitive Na+ Channel Current IC50 (mM) |
TTX-Resistant Na+ Channel Current IC50 (mM) |
References | |
---|---|---|---|---|---|
Acetic Acid-Based | Diclofenac | 0.94 | 0.00851, 0.014 | ca. 20% reduction (0.3 mM) |
[21,108,110,115] |
Aceclofenac | 0.47 | [21] | |||
Indomethacin | 38% reduction (1 mM) | [21] | |||
Acemetacin | 38% reduction (0.5 mM) | [21] | |||
Etodolac | 15% reduction (1 mM) | [21] | |||
Sulindac | n.d. (no effect, 1 mM) |
[21] | |||
Felbinac | n.d. (no effect, 1 mM) |
[21] | |||
Fenamic Acid-Based | Tolfenamic acid | 0.29 | ca. 70% reduction (0.1 mM) | ca. 30% reduction (0.1 mM) | [21,116] |
Meclofenamic acid | 0.19 | [21] | |||
Mefenamic acid | 16% reduction (0.2 mM) | [21] | |||
Flufenamic acid | 0.22 | ca. 60% reduction (0.1 mM) |
ca. 30% reduction (0.1 mM) |
[21,116] | |
0.189 | [114] | ||||
Salicylic Acid-Based |
Aspirin | n.d. (no effect, 1 mM) |
[21] | ||
Propionic Acid-Based |
Ketoprofen | n.d. (no effect, 1 mM) |
[21] | ||
Naproxen | n.d. (no effect, 1 mM) |
[21] | |||
Ibuprofen | n.d. (no effect, 1 mM) |
[21] | |||
Loxoprofen | n.d. (no effect, 1 mM) |
[21] | |||
Flurbiprofen | n.d. (no effect, 1 mM) |
[21] | |||
Enolic Acid-Based |
Meloxicam | n.d. (no effect, 0.5 mM) |
[21] | ||
Piroxicam | n.d. (no effect, 1 mM) |
[21] |
Here, when IC50 values are not available, it is partly shown for comparison how the CAPs and channels are affected by drugs, where % value indicates the extent of the reduction at the concentration shown in parentheses; n.d.: not determined.